(VIANEWS) – Camtek Ltd. (CAMT), Amgen (AMGN), Molina Healthcare (MOH) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Camtek Ltd. (CAMT)
29.3% sales growth and 20.32% return on equity
Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for the advanced interconnect packaging, memory, complementary metal oxide semiconductor image sensors, micro-electro mechanical systems, radio frequency, and other segments of the semiconductor industry. It provides inspection and metrology systems, including Eagle-i, a system that delivers 2D inspection and metrology capabilities; Eagle-AP, which addresses the advanced packaging market using software and hardware technologies that deliver superior 2D and 3D inspection and metrology capabilities on the same platform; and Golden Eagle, a panel inspection and metrology system to support fanout wafer level packaging applications. The company sells its products in the Asia Pacific, the United States, and Europe. Camtek Ltd. was incorporated in 1987 and is headquartered in Migdal HaEmek, Israel.
Earnings Per Share
As for profitability, Camtek Ltd. has a trailing twelve months EPS of $1.79.
PE Ratio
Camtek Ltd. has a trailing twelve months price to earnings ratio of 73.88. Meaning, the purchaser of the share is investing $73.88 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.32%.
Volume
Today’s last reported volume for Camtek Ltd. is 706975 which is 55.16% above its average volume of 455622.
Moving Average
Camtek Ltd.’s value is way above its 50-day moving average of $103.58 and way higher than its 200-day moving average of $78.46.
2. Amgen (AMGN)
22.3% sales growth and 72.57% return on equity
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
Earnings Per Share
As for profitability, Amgen has a trailing twelve months EPS of $12.48.
PE Ratio
Amgen has a trailing twelve months price to earnings ratio of 21.42. Meaning, the purchaser of the share is investing $21.42 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 72.57%.
Previous days news about Amgen(AMGN)
- According to Zacks on Monday, 15 July, "Home Depot (HD), Caterpillar (CAT) and Amgen (AMGN) provided the biggest boost to the Dow Jones index (read: Should Investors Diversify From Technology? "
3. Molina Healthcare (MOH)
20.5% sales growth and 27.53% return on equity
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Earnings Per Share
As for profitability, Molina Healthcare has a trailing twelve months EPS of $18.41.
PE Ratio
Molina Healthcare has a trailing twelve months price to earnings ratio of 16.1. Meaning, the purchaser of the share is investing $16.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.53%.
4. Badger Meter (BMI)
17.8% sales growth and 20.59% return on equity
Badger Meter, Inc. manufactures and markets flow measurement, quality, control, and communication solutions in the United States, Asia, Canada, Europe, Mexico, the Middle East, and internationally. It offers mechanical or static water meters, and related radio and software technologies and services to municipal water utilities. The company also provides flow instrumentation products, including meters, valves, and other sensing instruments to measure and control fluids going through a pipe or pipeline, including water, air, steam, oil, and other liquids and gases to original equipment manufacturers as the primary flow measurement device within a product or system, as well as through manufacturers' representatives. Its flow instrumentation products are used in water/wastewater, heating, ventilating and air conditioning, and corporate sustainability markets. In addition, the company offers ORION Migratable for automatic meter reading; ORION (SE) for traditional fixed network applications; and ORION Cellular for infrastructure-free fixed network meter reading solution, as well as BEACON advanced metering analytics, a secure cloud-hosted software suite that establishes alerts for specific conditions and allows consumer engagement tools that permit end water customers to view and manage their water usage activity. It also serves water utilities, industrial, and other industries. The company sells its products directly, as well as through resellers and representatives. Badger Meter, Inc. was founded in 1905 and is headquartered in Milwaukee, Wisconsin.
Earnings Per Share
As for profitability, Badger Meter has a trailing twelve months EPS of $3.47.
PE Ratio
Badger Meter has a trailing twelve months price to earnings ratio of 53.25. Meaning, the purchaser of the share is investing $53.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.59%.
Yearly Top and Bottom Value
Badger Meter’s stock is valued at $184.77 at 20:22 EST, below its 52-week high of $202.81 and way above its 52-week low of $134.06.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 23, 2024, the estimated forward annual dividend rate is 1.08 and the estimated forward annual dividend yield is 0.58%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 23.4%, now sitting on 740.77M for the twelve trailing months.
Moving Average
Badger Meter’s worth is below its 50-day moving average of $189.66 and way above its 200-day moving average of $160.46.
Previous days news about Badger Meter(BMI)
- According to Zacks on Monday, 15 July, "Concerning looming surprises, Wingstop (WING Quick QuoteWING – Free Report) , Badger Meter (BMI Quick QuoteBMI – Free Report) , and Packaging Corporation of America (PKG Quick QuotePKG – Free Report) could deliver just that, with each boasting a positive Earnings ESP Score and a favorable Zacks Rank.", "And concerning earnings positivity, all three companies above - Wingstop (WING Quick QuoteWING – Free Report) , Badger Meter (BMI Quick QuoteBMI – Free Report) , and Packaging Corporation of America (PKG Quick QuotePKG – Free Report) - could all bring precisely that, with each carrying a favorable Zacks Rank and a positive Earnings ESP score."
5. Hillenbrand (HI)
15.4% sales growth and 5.45% return on equity
Hillenbrand, Inc. operates as a diversified industrial company in the United States and internationally. It operates through three segments: Advanced Process Solutions, Molding Technology Solutions, and Batesville. The Advanced Process Solutions segment designs, engineers, manufactures, markets, and services process and material handling equipment and systems comprising compounding, extrusion, and material handling equipment, as well as offers equipment system design services; and provides screening and separating equipment for various industries, including plastics, food and pharmaceuticals, chemicals, fertilizers, minerals, energy, wastewater treatment, forest products, and other general industrials. The Molding Technology Solutions segment offers injection molding and extrusion equipment; hot runner systems; process control systems; and mold bases and components for various industries, including automotive, consumer goods, medical, packaging, construction, and electronics. The Batesville segment designs, manufactures, distributes, and sells funeral services products and solutions, such as burial caskets, cremation caskets, containers and urns, other personalization and memorialization products, and web-based technology applications. The company was founded in 1906 and is headquartered in Batesville, Indiana.
Earnings Per Share
As for profitability, Hillenbrand has a trailing twelve months EPS of $1.18.
PE Ratio
Hillenbrand has a trailing twelve months price to earnings ratio of 32.93. Meaning, the purchaser of the share is investing $32.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.45%.
Yearly Top and Bottom Value
Hillenbrand’s stock is valued at $38.86 at 20:22 EST, way under its 52-week high of $53.67 and higher than its 52-week low of $37.19.
Sales Growth
Hillenbrand’s sales growth for the next quarter is 15.4%.
6. Synopsys (SNPS)
8.4% sales growth and 21.58% return on equity
Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. It also provides intellectual property (IP) solutions for USB, PCI Express, DDR, Ethernet, MIPI, HDMI, and Bluetooth low energy applications; logic libraries and embedded memories; processor cores, software, and application-specific instruction-set processor tools for embedded applications; security IP solutions; IP solutions for automotive market; and system-on-chip (SoC) infrastructure IP, datapath and building block IP, and verification IP products, as well as mathematical and floating-point components, and Arm AMBA interconnect fabric and peripherals. In addition, the company offers HAPS FPGA-based prototyping systems; virtual prototyping solutions; and Platform Architect solutions for SoC architecture analysis and optimization, as well as optical products, and mechatronic simulations. Further, it provides security and quality testing products, managed services, programs and professional services, and training that enable its customers to detect and remediate security vulnerabilities, and defects in the software development lifecycle, as well as manufacturing solutions. Additionally, the company provides intelligent orchestration solution, software risk manager, and black duck software composition analysis tools. It serves electronics, financial services, automotive, medicine, energy, and industrial areas. The company was incorporated in 1986 and is headquartered in Sunnyvale, California.
Earnings Per Share
As for profitability, Synopsys has a trailing twelve months EPS of $9.04.
PE Ratio
Synopsys has a trailing twelve months price to earnings ratio of 61.63. Meaning, the purchaser of the share is investing $61.63 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.58%.
Yearly Top and Bottom Value
Synopsys’s stock is valued at $557.16 at 20:22 EST, way below its 52-week high of $629.38 and way higher than its 52-week low of $418.51.
Moving Average
Synopsys’s worth is under its 50-day moving average of $581.46 and higher than its 200-day moving average of $543.64.
7. Expedia Group (EXPE)
6.9% sales growth and 25.51% return on equity
Expedia Group, Inc. operates as an online travel company in the United States and internationally. The company operates through B2C, B2B, and trivago segments. Its B2C segment includes Brand Expedia, a full-service online travel brand offers various travel products and services; Hotels.com for lodging accommodations; Vrbo, an online marketplace for the alternative accommodations; Orbitz, Travelocity, Wotif Group, ebookers, CheapTickets, Hotwire.com and CarRentals.com. The company's B2B segment provides various travel and non-travel companies including airlines, offline travel agents, online retailers, corporate travel management, and financial institutions who leverage its travel technology and tap into its diverse supply to augment their offerings and market Expedia Group rates and availabilities to its travelers. Its trivago segment, a hotel metasearch website, which send referrals to online travel companies and travel service providers from hotel metasearch websites. In addition, the company provides brand advertising through online and offline channels, loyalty programs, mobile apps, and search engine marketing, as well as metasearch, social media, direct and personalized traveler communications on its websites, and through direct e-mail communication with its travelers. The company was formerly known as Expedia, Inc. and changed its name to Expedia Group, Inc. in March 2018. Expedia Group, Inc. was founded in 1996 and is headquartered in Seattle, Washington.
Earnings Per Share
As for profitability, Expedia Group has a trailing twelve months EPS of $5.32.
PE Ratio
Expedia Group has a trailing twelve months price to earnings ratio of 24.52. Meaning, the purchaser of the share is investing $24.52 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.51%.
Sales Growth
Expedia Group’s sales growth is 5.2% for the present quarter and 6.9% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 4.8% and 17%, respectively.
Volume
Today’s last reported volume for Expedia Group is 2004970 which is 22.54% below its average volume of 2588500.
